7KF-16506-79687
4 vaccinations
1 coded response
48 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Registered in v-safe
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-30
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-23
- 2021-04-27
- 2021-05-04
- 2021-05-13
- 2021-05-18
- 2021-07-06
- 2021-10-05
-
2021-10-08
Dose 3 — Pfizer-BioNTech
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-22
-
2021-10-29
Survey response — day 21, dose 3MedDRA: Heavy menstrual bleeding, Menstruation irregular — Feeling: GoodFree text: My menstrual cycle was a week earlier and much heavier than normal. The only thing that changed was my covid booster.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-11-14
- 2021-11-19
- 2022-01-07
- 2022-04-08
-
2022-09-07
Dose 4 — Pfizer-BioNTech
- 2022-09-07
- 2022-09-08
- 2022-09-09
- 2022-09-10
- 2022-09-11
- 2022-09-12
- 2022-09-21
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-12-07
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-09-07 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 3
Symptoms: My menstrual cycle was a week earlier and much heavier than normal. The only thing that changed was my covid booster.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release